Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Quinn

Showing results (601-610 of 635) with videos related to

Pageof 64
Sort By:
Neurobiology of Aging|May 21, 2017
Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's diseaseIgnacio F Mata, Catherine O Johnson, James B Leverenz, et al.
Journal of Extracellular Vesicles|July 19, 2017
Analysis of extracellular RNA in cerebrospinal fluidJulie A Saugstad, Theresa A Lusardi, Kendall R Van Keuren-Jensen, et al.
Dentistry Journal|August 27, 2025
Optimizing Preclinical Skill Assessment for Handpiece-Naïve Students: A Strategic ApproachReinhard Chun Wang Chau, Szabolcs Felszeghy, Maria F Sittoni-Pino, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseM Britschgi, C E Olin, H T Johns, et al.
Nature Nanotechnology|November 6, 2019
A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic painPaulina D Ramírez-García, Jeffri S Retamal, Priyank Shenoy, et al.
BMC Biology|October 11, 2007
Broadening the horizon--level 2.5 of the HUPO-PSI format for molecular interactionsSamuel Kerrien, Sandra Orchard, Luisa Montecchi-Palazzi, et al.
The Lancet. Neurology|December 17, 2016
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysisDavid J Irwin, Murray Grossman, Daniel Weintraub, et al.
JAMA Neurology|September 3, 2014
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson diseaseIgnacio F Mata, James B Leverenz, Daniel Weintraub, et al.
Blood|September 6, 2018
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signatureMichael A Chapman, Jonathan Sive, John Ambrose, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
Common variation in the LRRK2 gene is a risk factor for Parkinson's diseaseIgnacio F Mata, Harvey Checkoway, Carolyn M Hutter, et al.
Pageof 64

Showing results (601-610 of 635) with videos related to

Sort By:
Pageof 64
Neurobiology of Aging|May 21, 2017
Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's diseaseIgnacio F Mata, Catherine O Johnson, James B Leverenz, et al.
Journal of Extracellular Vesicles|July 19, 2017
Analysis of extracellular RNA in cerebrospinal fluidJulie A Saugstad, Theresa A Lusardi, Kendall R Van Keuren-Jensen, et al.
Dentistry Journal|August 27, 2025
Optimizing Preclinical Skill Assessment for Handpiece-Naïve Students: A Strategic ApproachReinhard Chun Wang Chau, Szabolcs Felszeghy, Maria F Sittoni-Pino, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseM Britschgi, C E Olin, H T Johns, et al.
Nature Nanotechnology|November 6, 2019
A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic painPaulina D Ramírez-García, Jeffri S Retamal, Priyank Shenoy, et al.
BMC Biology|October 11, 2007
Broadening the horizon--level 2.5 of the HUPO-PSI format for molecular interactionsSamuel Kerrien, Sandra Orchard, Luisa Montecchi-Palazzi, et al.
The Lancet. Neurology|December 17, 2016
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysisDavid J Irwin, Murray Grossman, Daniel Weintraub, et al.
JAMA Neurology|September 3, 2014
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson diseaseIgnacio F Mata, James B Leverenz, Daniel Weintraub, et al.
Blood|September 6, 2018
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signatureMichael A Chapman, Jonathan Sive, John Ambrose, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
Common variation in the LRRK2 gene is a risk factor for Parkinson's diseaseIgnacio F Mata, Harvey Checkoway, Carolyn M Hutter, et al.
Pageof 64